![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, December 19, 2011 6:07:14 PM
December 19, 2011: NanoLogix Instructs Battelle to Prepare US FDA Submittals
NanoLogix has instructed Battelle BioMedical Research Center to prepare the following for submittal to the US FDA, for a total of six separate applications.
1) Results of Battelle TB tests for approval for use as a BSL-3 test process for Tuberculosis using NanoLogix BNP technology
2) Results of the University of Texas Health Science Center-Houston Group B Streptoccocus tests (currently ongoing) for use as a recognized test kit using NanoLogix BNF technology
3) Results of multiple tests performed by Battelle on gram-positive bacteria with BNP and BNF technologies for approval as recognized tests for the gram-positive family of bacteria
4) Results of multiple tests performed by Battelle on gram-negative bacteria with BNP and BNF technologies for approval as recognized tests for the gram-negative family of bacteria
All tests and data collection have been performed by independent third-party laboratories and will be submitted to the US FDA by third parties. As such, NanoLogix does not control the timeline for the submission process.
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM